Adam C Kaufman

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease

Kewei Chen, Eric M Reiman, Pradeep Varma, 2015, Alzheimer's Research & Therapy.